Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Goss

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Breast Cancer Research and Treatment|October 4, 2000
Characterization of a novel silencer element in the human aromatase gene PII promoterT Jin, X Zhang, H Li, et al.
Biochemical Pharmacology|September 1, 1986
Pyridoglutethimide [3-ethyl-3-(4-pyridyl)-piperidine-2,6-dione], an analogue of aminoglutethimide. Metabolism and pharmacokineticsA Seago, P E Goss, L J Griggs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignanciesP E Goss, C L Reid, D Bailey, et al.
Journal of Steroid Biochemistry|February 1, 1986
Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the ratP E Goss, M Jarman, J R Wilkinson, et al.
Journal of the National Cancer Institute|January 1, 1992
Phase I trial of granulocyte-macrophage colony-stimulating factor with high-dose cisplatin and etoposide for treatment of small-cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials GroupF A Shepherd, P E Goss, J Rusthoven, et al.
Cancer|March 26, 1999
Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996P E Goss, C Reid, M Pintilie, et al.
Cancer Treatment Reports|June 1, 1986
High-dose oral medroxyprogesterone acetate in heavily pretreated patients with metastatic breast cancerP E Goss, S Ashley, T J Powles, et al.
Oncogene|June 8, 1999
Chromosomal deletions occur in restricted regions of 5q in testicular germ cell cancerH Q Peng, L Liu, P E Goss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponadeG Liu, M Crump, P E Goss, et al.
Oncology|February 9, 1999
Rivizor--a new third-generation aromatase inhibitor for the treatment of advanced breast cancer after tamoxifen failureP E Goss, D Walde, R De Coster, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Breast Cancer Research and Treatment|October 4, 2000
Characterization of a novel silencer element in the human aromatase gene PII promoterT Jin, X Zhang, H Li, et al.
Biochemical Pharmacology|September 1, 1986
Pyridoglutethimide [3-ethyl-3-(4-pyridyl)-piperidine-2,6-dione], an analogue of aminoglutethimide. Metabolism and pharmacokineticsA Seago, P E Goss, L J Griggs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignanciesP E Goss, C L Reid, D Bailey, et al.
Journal of Steroid Biochemistry|February 1, 1986
Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the ratP E Goss, M Jarman, J R Wilkinson, et al.
Journal of the National Cancer Institute|January 1, 1992
Phase I trial of granulocyte-macrophage colony-stimulating factor with high-dose cisplatin and etoposide for treatment of small-cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials GroupF A Shepherd, P E Goss, J Rusthoven, et al.
Cancer|March 26, 1999
Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996P E Goss, C Reid, M Pintilie, et al.
Cancer Treatment Reports|June 1, 1986
High-dose oral medroxyprogesterone acetate in heavily pretreated patients with metastatic breast cancerP E Goss, S Ashley, T J Powles, et al.
Oncogene|June 8, 1999
Chromosomal deletions occur in restricted regions of 5q in testicular germ cell cancerH Q Peng, L Liu, P E Goss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponadeG Liu, M Crump, P E Goss, et al.
Oncology|February 9, 1999
Rivizor--a new third-generation aromatase inhibitor for the treatment of advanced breast cancer after tamoxifen failureP E Goss, D Walde, R De Coster, et al.
Pageof 8